GSK Strikes AI Deal With Relation Therapeutics To Boost Drug Development
Deals·1 article across 1 outlet
Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data
GSK Plc agreed another deal with British biotech Relation Therapeutics Ltd. to use artificial intelligence to speed up drug development.
This partnership aims to enhance GSK's early pipeline by leveraging AI technology in the drug development process.
GSKRelation Therapeutics
Sources
Every quote below is verbatim from the article it is attributed to.
SourceReports the news
“GSK Plc agreed another deal with British biotech Relation Therapeutics Ltd. to use artificial intelligence to speed up drug development.”
Bloomberg — GSK Strikes AI Deal With UK Biotech to Boost Early Pipeline